GMP Production Facility

Biopharma Group?s state-of-the-art GMP (Good Manufacturing Practice) freeze drying production facility supports partners with the transition of their product from the research and development phase into clinical manufacture. The UK based GMP facility has been designed to accommodate small batch manufacture of both cyto and non-cytotoxic products for first-in-human (FIH) trials. Biopharma Group offers access to fast and efficient GMP manufacturing slots paired with flexible manufacturing solutions to enable the delivery of projects on time and within budget.

Biopharma Group?s team understands the challenges around transitioning products from R&D into GMP manufacture. With a world leading reputation for research and development, our skilled scientists are on hand to support with process optimization requirements and tech transfer both in, and out of our UK facility.

For further information visit our website, leave us a message or find the contact details to speak to our specialist team.

For more information on GMP Production Facility talk to Biopharma Group